Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes
Get Live Data
160.00    1.25 (0.79%)
Bid:
154.00
Ask:
160.00
Spread: 6.00 (3.896%)
Market Cap: £1.38b
HCM Live PriceLast checked at - London Stock Exchange

Intraday Hutchmed Share Chart

Thursday broker round-up - UPDATE

Thu, 12th Jan 2012 09:08
Reckitt Benckiser: J.P. Morgan Cazenove downgrades to neutral from overweight.Tesco: Nomura reiterates buy rating and 500p target; Panmure Gordon cuts target from 500p to 440p, buy rating unchanged.Royal Bank of Scotland: Shore Capital reiterates sell.Tesco: Shore Capital downgrades to hold from buy.Sainsbury: Credit Suisse reiterates underweight. HSBC: Bank of America-Merrill Lynch cuts to underperform from neutral. Sainsbury: Nomura keeps neutral rating and 300p target.Morrison: Nomura keeps buy stance and 350p target.British Sky Broadcasting: UBS downgrades from buy to neutral, target cut from 860p to 740p; Investec downgrades from buy to hold, target cut from 760p to 700p.Lloyds: AlphaValue downgrades from buy to add, target raised from 34.5p to 34.8p.WPP: UBS upgrades from neutral to buy, target hiked from 675p to 840p.Micro Focus International: UBS downgrades from buy to neutral, target raised from 430p to 440p.Thomas Cook: AlphaValue upgrades from sell to add, target raised from 6.8p to 17.6p.Home Retail: Investec puts 57p target under review, sell rating maintained; Panmure Gordon keeps sell rating and 60p target.Halfords: Investec cuts target from 355p to 325p, buy rating kept; Panmure Gordon keeps hold and 300p target.FirstGroup: Investec reiterates buy and 380p target.Computacenter: Investec keeps buy and 500p target; Panmure Gordon raises target from 482p to 490p, buy rating unchanged.Ocado: Panmure Gordon reiterates sell and 50p target.JD Sports Fashion" Investec maintains buy and 980p target.Mothercare: Investec puts 125p target under review, sell rating unchanged; Panmure Gordon slashes target from 145p to 88p, sell rating unchanged.Booker: Investec raises target from 80p to 82p, buy rating unchanged.Barratt Developments: Panmure Gordon reiterates buy and 158p target.Associated British Foods: Panmure Gordon keeps buy rating and 1,300p target.Psion: finnCap upgrades from sell to hold, target left at 45p.Telecity: UBS downgrades from buy to neutral, target raised from 665p to 700p.Hutchison China Meditech: UBS reduces target from 540p to 460p, buy rating unchanged.Thorntons:Investec slashes target from 35p to 15p, hold rating kept.

Related News

LONDON MARKET CLOSE: FTSE 100 falls as OpenAI delay report knocks tech
1 day ago

LONDON MARKET CLOSE: FTSE 100 falls as OpenAI delay report knocks tech

(Alliance News) - The FTSE 100 ended lower on Friday while technology stocks fell as the New York Times reported OpenAI may delay its initial public o...

WINNERS & LOSERS: Distribution Finance optimistic for annual results
1 day ago

WINNERS & LOSERS: Distribution Finance optimistic for annual results

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday.

Hutchmed News

Hutchmed China reports positive phase two fanregratinib study data
2 days ago

Hutchmed China reports positive phase two fanregratinib study data

(Alliance News) - Hutchmed China Ltd on Thursday reported positive phase two data for fanregratinib in patients with intrahepatic cholangiocarcinoma, ...

Hutchmed highlights data for sovleplenib in rare blood disorder
12 Jun 2026

Hutchmed highlights data for sovleplenib in rare blood disorder

(Alliance News) - Hutchmed China Ltd on Friday said phase III trial results for its investigational drug sovleplenib showed significant efficacy and a...

TRADING UPDATES: Tungsten secures loan; Ashtead trading in line
21 May 2026

TRADING UPDATES: Tungsten secures loan; Ashtead trading in line

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

EARNINGS AND TRADING: AltynGold reports annual revenue surge
29 Apr 2026

EARNINGS AND TRADING: AltynGold reports annual revenue surge

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately repor...

Hutchmed begins phase-three trials of lymphoma therapy in China
23 Mar 2026

Hutchmed begins phase-three trials of lymphoma therapy in China

(Alliance News) - Hutchmed China Ltd on Monday said it had begun phase-three clinical trials of its lymphoma treatment in China.

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich
23 Mar 2026

LONDON BRIEFING: GSK gains Japan nod; Anglo to delist shares in Zurich

(Alliance News) - GSK makes regulatory progress in Japan for a cancer therapy, Anglo American moves to delist from the Swiss exchange as part of its r...

Hutchmed shares slide as recalls cancer treatment Tazverik
9 Mar 2026

Hutchmed shares slide as recalls cancer treatment Tazverik

(Alliance News) - Hutchmed China Ltd on Monday saw its shares fall after reporting the withdrawal of a cancer medication which it licenses from Ipsen ...